(Q41596914)

4 October 2017

1 reference

title

Towards efficient cell targeting by recombinant retroviruses (English)

1 reference

4 October 2017

Marin M

1

1 reference

4 October 2017

Noël D

series ordinal

2

1 reference

4 October 2017

Piechaczyk M

series ordinal

3

1 reference

4 October 2017

publication date

1 September 1997

1 reference

Trends in Molecular Medicine

4 October 2017

published in

1 reference

4 October 2017

volume

3

1 reference

4 October 2017

issue

9

1 reference

4 October 2017

page(s)

396-403

1 reference

Gene therapy for metabolic disorders

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Transfer of genes to humans: early lessons and obstacles to success

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Virus vector design in gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Targeted vectors for gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

1 reference

7 January 2021

GENETIC CONTROL OF CELLULAR SUSCEPTIBILITY TO PSEUDOTYPES OF ROUS SARCOMA VIRUS.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Retroviral retargeting by envelopes expressing an N-terminal binding domain.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Targeting retroviral vectors to specific cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Retroviral vectors displaying functional antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Efficient incorporation of human CD4 protein into avian leukosis virus particles

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2897%2901095-2

7 January 2021

10.1016/S1357-4310(97)01095-2

Identifiers

DOI

1 reference

4 October 2017

1 reference